TRDA Insider Buying
The table below summarizes the most recent TRDA insider buying information — the latest buy being $29,316.00 by Bernhardt G. Zeiher on 5/20/2026, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why TRDA insider buys like these are important for investors to follow.
| Date | Insider | Price | Amount |
|---|---|---|---|
| 5-20-2026 Insider Buy |
Bernhardt G. Zeiher Director |
$5.86 CAGR » |
$29,316.00 5,000 shares |
| 11-20-2025 Insider Buy |
BROS. Advisors LP Baker |
$9.07 CAGR » |
$261,846.12 28,867 shares |
| 11-12-2025 Insider Buy |
BROS. Advisors LP Baker |
$7.60 CAGR » |
$1,352,586.68 178,044 shares |
| 5-14-2024 Insider Buy |
Peter S. Kim Director |
$14.63 CAGR » |
$731,682.50 50,000 shares |
| 5-14-2024 Insider Buy |
Peter S. Kim Director |
$14.59 CAGR » |
$364,672.50 25,000 shares |
| 4-8-2024 Insider Buy |
Peter S. Kim Director |
$13.57 CAGR » |
$35,289.80 2,600 shares |
| 3-28-2024 Insider Buy |
Peter S. Kim Director |
$13.75 CAGR » |
$20,793.93 1,512 shares |
| 3-26-2024 Insider Buy |
Peter S. Kim Director |
$13.58 CAGR » |
$122,881.82 9,048 shares |
| 3-21-2024 Insider Buy |
Peter S. Kim Director |
$12.81 CAGR » |
$34,995.55 2,732 shares |
| 6-6-2022 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$6.37 CAGR » |
$260,759.62 40,947 shares |
| 5-24-2022 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$5.82 CAGR » |
$282,447.24 48,509 shares |
| 5-18-2022 Insider Buy |
BROS. Advisors LP Baker >10% Owner |
$5.99 CAGR » |
$430,700.75 71,944 shares |
| 1-12-2022 Insider Buy |
John F. Crowley Director |
$9.71 CAGR » |
$48,575.00 5,000 shares |
| 11-2-2021 Insider Buy |
Kush Parmar Director and >10% Owner |
$20.00 CAGR » |
$5,000,000.00 250,000 shares |
| 11-2-2021 Insider Buy |
Redmile Group, LLC >10% Owner |
$20.00 CAGR » |
$20,000,000.00 1,000,000 shares |
| 11-2-2021 Insider Buy |
5AM Ventures V, L.P. >10% Owner |
$20.00 CAGR » |
$5,000,000.00 250,000 shares |
| 11-2-2021 Insider Buy |
Todd Foley Director and >10% Owner |
$20.00 CAGR » |
$2,000,000.00 100,000 shares |
| 11-2-2021 Insider Buy |
MPM BioVentures 2014, L.P. >10% Owner |
$20.00 CAGR » |
$2,000,000.00 100,000 shares |
| 11-2-2021 Insider Buy |
MPM BIOVENTURES 2018, L.P. >10% Owner |
$20.00 CAGR » |
$2,000,000.00 100,000 shares |
Also See: SEC filings
Entrada Therapeutics Insider Purchase CAGR Analysis
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 05/21/2026 | |
| End date: | 10/06/2026 | |
| Start price/share: | $6.31 | |
| End price/share: | $5.42 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -14.10% | |
| Annualized Gain: | -37.31% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $8,590.00 | |
| Years: | 0.38 | |
